More articles about: Thyroid Cancer

Megan R. Haymart, M.D., and Maria Papaleontioui, M.D., both received awards from the the American Thyroid Association.

Teen hockey player Gavin Hewitt was diagnosed with papillary thyroid cancer and underwent surgery and radioactive iodine treatment.

The American Cancer Society reports that mortality rates have continued to decline since the 1990s. N. Lynn Henry, of Michigan Medicine, answers questions about how factors such as healthy lifestyle choices, early screening and clinical trials have improved cancer survival rates.

The American Thyroid Association first published guidelines for managing differentiated thyroid cancer in 1996. The current updates consider every aspect of the patient’s journey, including diagnosis, monitoring and treatment. Megan Haymart answers questions about understanding the risk for thyroid cancer, active surveillance and current treatment options.

For thyroid cancer, experts examine the current state of overdiagnosis, new therapies, health equity concerns and more.

An endocrinologist specializing in thyroid cancer and creator of the Hemoglobin A1c test for diabetes reflects on his career, offering advice for aspiring researchers.

While most thyroid ultrasound orders are warranted, researchers say guidelines could be clearer to help reduce over diagnosis of thyroid cancer.

Better shared decision-making could help patients feel more empowered, avoid treatment side-effects and reduce overtreatment.

Learn when active surveillance of low risk thyroid, prostate and breast cancer, may be appropriate and whether this approach could reduce overtreatment.

A large, population-based study identifies three groups most at risk of postoperative complications.

Study finds specifically follicular and medullary thyroid cancer metastasis to bone has a low survival rate prompting great drug research.

University of Michigan researchers found that despite rapid growth in post-treatment imaging of thyroid cancer, survival rates have not improved. Find out why.

Researchers at the University of Michigan suggest categorizing non-life-threatening thyroid tumors separately from more aggressive thyroid cancers.